XML 11 R3.htm IDEA: XBRL DOCUMENT v3.22.1
CONSOLIDATED STATEMENT OF COMPREHENSIVE LOSS
$ in Thousands
 12 Months Ended
Dec. 31, 2021
USD ($)
$ / shares
shares
Dec. 31, 2020
USD ($)
$ / shares
shares
Dec. 31, 2019
USD ($)
$ / shares
shares
Revenues $ 6 $ 388 $ 681
Cost of sales 995 647 490
Gross loss (989) (259) 191
Operating expenses:      
Research and development expenses, net 252,424 29,589 7,038
Selling, general and administrative expenses 262,083 38,250 7,178
Total operating expenses 514,507 67,839 14,216
Operating loss (515,496) (68,098) (14,025)
Income from warrants remeasurement 11,024 0 0
Financial income, net 423 385 1,830
Net loss before income tax (504,049) (67,713) (12,195)
Income tax expense 1,281 0 0
Net loss (505,330) (67,713) (12,195)
Net comprehensive loss $ (505,330) $ (67,713) $ (12,195)
Weighted average number of ordinary shares and preferred shares used in computing basic net loss per share (in shares) | shares 235,612,764 155,930,380 126,592,395
Weighted average number of ordinary shares and preferred shares used in computing diluted net loss per share (in shares) | shares 235,612,764 155,930,380 126,592,395
Ordinary shares - Class A      
Operating expenses:      
Basic net loss per share (in USD per share) | $ / shares $ (2.14) $ (0.43) $ (0.10)
Diluted net loss per share (in USD per share) | $ / shares $ (2.14) $ (0.43) $ (0.10)